BRPI0415945A - uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões - Google Patents

uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões

Info

Publication number
BRPI0415945A
BRPI0415945A BRPI0415945-4A BRPI0415945A BRPI0415945A BR PI0415945 A BRPI0415945 A BR PI0415945A BR PI0415945 A BRPI0415945 A BR PI0415945A BR PI0415945 A BRPI0415945 A BR PI0415945A
Authority
BR
Brazil
Prior art keywords
extracts
treatment
depressions
opuntia
parts
Prior art date
Application number
BRPI0415945-4A
Other languages
English (en)
Inventor
Michael Noeldner
Karl Schoetz
Original Assignee
Bioplanta Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioplanta Arzneimittel Gmbh filed Critical Bioplanta Arzneimittel Gmbh
Publication of BRPI0415945A publication Critical patent/BRPI0415945A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

"USO DE PARTES DE PLANTAS DE PêRA ESPINHOSA (OPUNTIA) E/OU EXTRATOS DA MESMA PARA O TRATAMENTO DE DEPRESSõES". A presente invenção refere-se ao uso de Opuntias, partes de planta das mesmas e/ou extratos ou outras preparações produzidas a partir das mesmas, para o tratamento de episódios de depressão e doenças depressivas ou outros distúrbios afetivos, que possam ser influenciados por agentes antidepressivos, tais como, sensações de ansiedade e distúrbios de pânico, depressões bipolares, distúrbios de somatização e síndrome pré-menstrual, bem como os estágios preliminares de tais doenças.
BRPI0415945-4A 2003-10-28 2004-10-26 uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões BRPI0415945A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10350194A DE10350194B4 (de) 2003-10-28 2003-10-28 Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
PCT/EP2004/012070 WO2005041994A1 (de) 2003-10-28 2004-10-26 Verwendung von feigenkaktus (opuntia) pflanzenteilen und/oder extrakten behandlung von depressionen

Publications (1)

Publication Number Publication Date
BRPI0415945A true BRPI0415945A (pt) 2007-01-02

Family

ID=34529823

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415945-4A BRPI0415945A (pt) 2003-10-28 2004-10-26 uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões

Country Status (16)

Country Link
US (1) US20070134355A1 (pt)
EP (1) EP1682162B1 (pt)
JP (1) JP4863875B2 (pt)
KR (1) KR20070026329A (pt)
CN (1) CN1867346B (pt)
AT (1) ATE388719T1 (pt)
AU (1) AU2004285274B2 (pt)
BR (1) BRPI0415945A (pt)
CA (1) CA2544050C (pt)
DE (2) DE10350194B4 (pt)
ES (1) ES2299878T3 (pt)
PL (1) PL1682162T3 (pt)
PT (1) PT1682162E (pt)
RU (1) RU2336087C2 (pt)
UA (1) UA82895C2 (pt)
WO (1) WO2005041994A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885524B1 (fr) * 2005-05-10 2007-08-10 Silab Sa Procede d'obtention d'un actif cosmetique exfoliant, principe actif obtenu et compositions associees
WO2008038849A1 (en) * 2006-09-29 2008-04-03 Korea Institute Of Science And Technology Pharmaceutical composition comprising an extract from opuntia ficus-indica
IL182284A0 (en) * 2007-03-29 2008-01-20 Avi Gal A composition and method for inhibiting the enzyme 5 - alpha - reductase and the alpha - 1 - adrenergic receptor, treating related disorders, and a process for producing said composition
US7722904B2 (en) * 2007-11-01 2010-05-25 Access Business Group International Llc Compositions and methods for stimulating synthesis of pro-collagen or collagen and hyaluronic acid
EP2057994A1 (de) 2007-11-06 2009-05-13 Finzelberg GmbH & Co. KG Feigenkakteen-Extraktzubereitung
AT507988B1 (de) * 2009-01-15 2012-06-15 Kaahee Res And Dev Gmbh Kaktusfruchtextrakt
US20100209557A1 (en) * 2009-02-14 2010-08-19 O'connor Daniel C Recovery blends for liquid beverages
MX2012009288A (es) * 2010-02-11 2013-01-24 Schwabe Willmar Gmbh & Co Uso de triglicosidos de isorhamnetina.
MA34856B1 (fr) * 2012-07-09 2014-02-01 Mariam Minhaj Procédure d'obtenir une préparation à base des fleurs de cactus, et son utilisation
WO2020256243A1 (ko) * 2019-06-17 2020-12-24 한국한의학연구원 부채마와 백년초의 혼합추출물을 포함하는 우울증 예방 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621486D0 (en) * 1996-10-15 1996-12-04 Isis Innovation Oxygenase enzymes & method
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
GB9810092D0 (en) * 1998-05-11 1998-07-08 Merck Sharp & Dohme Therapeutic agents
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
MY124001A (en) * 1999-04-23 2006-06-30 E Excel Int Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
FR2823423B1 (fr) * 2001-04-11 2004-08-27 Bio Serae Laboratoires Preparation a base de cactaceae ayant la propriete de fixer les graisses, et procede d'obtention d'une telle preparation
KR100523562B1 (ko) * 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물

Also Published As

Publication number Publication date
JP4863875B2 (ja) 2012-01-25
AU2004285274A1 (en) 2005-05-12
ES2299878T3 (es) 2008-06-01
UA82895C2 (uk) 2008-05-26
KR20070026329A (ko) 2007-03-08
RU2006117208A (ru) 2007-12-10
DE10350194B4 (de) 2005-11-10
WO2005041994A1 (de) 2005-05-12
CN1867346B (zh) 2012-08-22
CN1867346A (zh) 2006-11-22
ATE388719T1 (de) 2008-03-15
PT1682162E (pt) 2008-03-28
RU2336087C2 (ru) 2008-10-20
EP1682162A1 (de) 2006-07-26
US20070134355A1 (en) 2007-06-14
DE502004006525D1 (de) 2008-04-24
CA2544050C (en) 2014-07-08
CA2544050A1 (en) 2005-05-12
AU2004285274B2 (en) 2009-12-24
JP2007509877A (ja) 2007-04-19
PL1682162T3 (pl) 2008-08-29
DE10350194A1 (de) 2005-06-16
EP1682162B1 (de) 2008-03-12

Similar Documents

Publication Publication Date Title
ECSP034916A (es) Oxazolidinonas substituidas para terapia de combinacion
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BRPI0409227A (pt) composto, composição farmacêutica, uso de um composto, intermediário, e, processo para a preparação de um composto
NO20075136L (no) Nye liposompreparater
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
ECSP066608A (es) Suspensiones acuosas de ciclesonide para nebulización
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0818533B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
GT200400116A (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
ATE396973T1 (de) Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
AR055095A1 (es) Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c
BR0312232A (pt) Inibidores de caspases e seus usos
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
UY28130A1 (es) Compuestos de indazol y composiciones farmaceuticaspara inhibr proteinquinasas, y procedimientos para su uso.
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
BRPI0414428A (pt) composições farmacêuticas
BRPI0408863A (pt) composto, composição farmacêutica, método para tratar doenças, e, uso de um composto.
BRPI0415945A (pt) uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões
Hameed et al. Characterization of antimicrobial metabolites produced by Salvadora persica and analysis of its chemical compounds using GC-MS and FTIR
BR112022001567A2 (pt) Derivados de isoquinolina e seu uso para o tratamento de infecções parasitárias.
ATE475408T1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
EA200600374A1 (ru) Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 35/78; A61K 31/135; A61P 25/24.

Ipc: A61K 31/352 (2006.01), A61K 31/7048 (2006.01)

Ipc: A61K 31/352 (2006.01), A61K 31/7048 (2006.01)